Autolus Therapeutics (AUTL) Receivables (2021 - 2025)
Autolus Therapeutics posted quarterly Receivables of $24.9 million for Q4 2025, up 4823.91% year-on-year from $506000.0 in Q4 2024, and down 25.72% on a QoQ basis from $33.5 million in Q3 2025.
Autolus Therapeutics (AUTL) has 5 years of Receivables data on file, last reported at $24.9 million in Q4 2025.
- For the quarter ending Q4 2025, Receivables rose 4823.91% year-over-year to $24.9 million; the trailing twelve-month figure through Dec 2025 stood at $24.9 million (up 4823.91% YoY), and the FY2025 full-year result was $24.9 million, up 4823.91% from the prior year.
- Receivables for Q4 2025 stood at $24.9 million, down from $33.5 million in the prior quarter.
- Across five years, Receivables topped out at $33.5 million in Q3 2025 and bottomed at $384000.0 in Q4 2021.
- The 5-year median for Receivables is $1.3 million (2022), against an average of $9.0 million.
- The widest annual swing landed in 2024, when Receivables slumped 76.29%; it then surged 5508.7% in 2025.
- A 5-year view of Receivables shows it stood at $384000.0 in 2021, then surged by 305.21% to $1.6 million in 2022, then slumped by 59.83% to $625000.0 in 2023, then slipped by 19.04% to $506000.0 in 2024, then surged by 4823.91% to $24.9 million in 2025.
- The last three Receivables figures came in at $24.9 million (Q4 2025), $33.5 million (Q3 2025), and $27.3 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | - |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | 13.10 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | 4.97 Mn |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 2.00 Bn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | 5.73 Bn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 883.96 Mn |
| 10 | Autolus Therapeutics | - | - | -1.04 Mn | 24.92 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 24.92 Mn |
| Sep 30, 2025 | 33.54 Mn |
| Jun 30, 2025 | 27.27 Mn |
| Mar 31, 2025 | 14.74 Mn |
| Dec 31, 2024 | 506,000.00 |
| Sep 30, 2024 | 598,000.00 |
| Jun 30, 2024 | 957,000.00 |
| Mar 31, 2024 | 736,000.00 |
| Dec 31, 2023 | 625,000.00 |
| Sep 30, 2023 | 2.52 Mn |
| Dec 31, 2022 | 1.56 Mn |
| Dec 31, 2021 | 384,000.00 |